What You Should Know:
- As the world prepares for the Inflation Reduction Act’s landmark policy changes, healthcare stakeholders realize that its wide-ranging effects will require new approaches to drug pricing, health plan design, and investment.
- Avalere’s ‘2023 Healthcare Industry Outlook’ examines how community-wide healthcare will be affected by a recent court ruling, and consider data’s role in addressing health disparities.
Key Trends in Healthcare in 2023
The main insights
Read More
Medicare Part D
8 Executive Pharmacy Predictions/Trends to Watch in 2023
Frank Harvey, CEO at Surescripts
Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work.
Greg
Read More
Walmart to Offer Medicare Insurance Plans During 2020 Open Enrollment
What You Should Know:
- Walmart announced it will begin selling Medicare
insurance plans during this year’s annual enrollment period, Oct. 15 through
Dec. 7.
Today, Walmart
announced the launch of Walmart
Insurance Services, LLC, a licensed insurance brokerage, which will assist
people with enrolling in insurance plans—and simplify what’s historically been
a cumbersome, confusing process. Walmart Insurance Services will begin selling
Medicare insurance plans during this year’s Annual
Read More
Surescripts Inks Partnerships with National Health Plans to Streamline Prior Authorization
Surescripts announced that several national, regional and local PBMs and health plans representing virtually all U.S. patients are replacing their manual prior authorization process with Surescripts Electronic Prior Authorization solution. Over the past 18 months, several national, regional and local PBMs and health plans representing virtually all U.S. patients have signed on, increasing the number of insured lives covered by Surescripts Electronic Prior Authorization by nearly 20%.Impact of
Read More
Imprivata Extends EPCS Support to Google Chrome for MEDITECH EHR Customers
Health IT company Imprivata, today announced that Imprivata Confirm ID, a comprehensive solution for electronic prescribing for controlled substances (EPCS), now supports EPCS within the Google Chrome Web browser. This makes Imprivata Confirm ID more accessible to MEDITECH customers as the best option for ensuring a fast, seamless, and fully compliant EPCS workflow for their prescribers.Growing Importance of EPCS for MEDITECH HospitalsIn response to America’s national opioid abuse epidemic, the
Read More
Imprivata Launches EPCS Support Hub to Support Medicare Part D
Imprivata has launched an online resource to help health organizations meet the requirements of a new federal law mandating the use of e-prescribing for controlled substances (EPCS) for all Medicare Part D subscriptions. The support hub, called "EPCS Ready", includes all the information needed to comply with the new federal law by the January 2021 deadline. It also includes insights & lessons learned from EPCS leaders, including the CMIO of Hartford HealthCare - where EPCS was implemented
Read More
